PVCT Stock Quote

PVCT Press Releases, Recent News

• Wednesday, September 01, 2010 8:35 AM EST
  Provectus Pharmaceuticals (OTC-BB: PVCT) Takes Aim at Psoriasis
  BiotechStockTrader.com - Sep 1, 2010

  By Justin Kuepper on Wednesday, September 1st, 2010 Provectus Pharmaceuticals, Inc. (OTC-BB: PVCT), a biotechnology company developing cancer and psoriasis treatments alongside companies like ...
• Wednesday, August 25, 2010 11:19 AM EST
  OTC ADVISORS, LLC: Huge Alert On: (OTCBB:NVNC) - (OTCBB:TRAB) - (OTCBB:PVCT)
  Trading Markets - Aug 25, 2010

  www.otc-advisors.com names (OTCBB: NVNC | PowerRating) Novo Energies Corp. (OTCBB: TRAB | PowerRating) TheraBiogen Inc. and (OTCBB: PVCT | PowerRating) Provectus Pharmaceutical, Inc. its "Bulls of ...
• Wednesday, August 25, 2010 10:18 AM EST
  Breakthroughstocks.net: EXPLOSIVE news on: (OTCBB:BLQN) - (OTCBB:KYNP) - (OTCBB:PVCT)
  Trading Markets - Aug 25, 2010

  www.breakthroughstocks.net names (OTCBB: BLQN | PowerRating) Balqon Corp., (OTCBB: KYNP | PowerRating) Keyuan Petrochemicals, Inc., and (OTCBB: PVCT | PowerRating) Provectus Pharmaceutical, Inc ...
• Wednesday, August 25, 2010 7:01 AM EST
  Provectus Pharmaceuticals Will Present at the Rodman & Renshaw 12th Annual Healthcare Conference on September 14, 2010
  Business Wire - Aug 25, 2010

  KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, will present at the ...

  Provectus Pharmaceuticals Will Present At The Rodman & Renshaw 12th Annual Healthcare Conference On September 14, 2010 - TheStreet.com
  
• Tuesday, August 17, 2010 11:01 PM EST
  Knox company enters clinical trial stage for cancer drug
  Knoxville News Sentinel - Aug 18, 2010

  By Carly Harrington Scientist Jamie Singer uses the red synthetic dye Rose Bengal in a dose response test at Provectus Pharmaceuticals Inc. Rose Bengal was originally developed in the late 19th ...
• Wednesday, August 04, 2010 4:37 PM EST
  SmarTrend's Trend Spotter Sees Continued Downward Momentum on Shares of Provectus Pharmaceuticals (PVCT)
  Benzinga - Aug 4, 2010

  SmarTrend identified a Downtrend for Provectus Pharmaceuticals (NASDAQ:PVCT) on May 06, 2010 at $1.12. In approximately 3 months, Provectus Pharmaceuticals has returned 11.2% as of today's recent ...
• Monday, August 02, 2010 9:51 AM EST
  Provectus (OTC-BB: PVCT) Partners to Facilitate Licensing Transactions for PH-10
  TheOTCInvestor.com - Aug 2, 2010

  By Justin Kuepper · Monday, August 2nd, 2010 Provectus Pharmaceuticals, Inc. (PVCT), which is developing cancer and dermatology treatments alongside companies like Genta Incorporated (GETA) and ...
• Monday, August 02, 2010 6:18 AM EST
  SmarTrend Watching for Rebound in Shares of Provectus Pharmaceuticals After 29.86% Loss (PVCT)
  Comtex Smartrend - Aug 2, 2010

  By Chip Brian Provectus Pharmaceuticals (NASDAQ:PVCT) traded in a range yesterday that spanned from a low of $0.96 to a high of $1.01. Yesterday, the shares fell 29.86%, which took the trading ...
• Friday, July 30, 2010 10:47 AM EST
  Provectus Scores Points with Numoda Capital! (OTCBB: PVCT)
  World Market Media - Jul 30, 2010

  Just 3 days ago, Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), signed an agreement with Numoda Capital Innovations LLC (http://www.numodacapital.com) to license its TruPoints ...
• Tuesday, July 27, 2010 9:39 AM EST
  Provectus Pharmaceuticals, Inc. (OTC:PVCT) Gains Considerable Recognition and Reports Accomplishments
  TheOTCInvestor.com - Jul 27, 2010

  By Luke Ruther · Tuesday, July 27th, 2010 Provectus Pharmaceuticals, Inc. (OTC:PVCT), which specializes in the development of clinical products designed to treat various cancers, similar to ...